ATLANTA--(BUSINESS WIRE)--
Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors in Alexion Pharmaceuticals, Inc. (“Alexion” or the “Company”) (NASDAQ: ALXN) who purchased shares between February 10, 2014 and November 9, 2016. The complaint alleges Alexion used unlawful sales practices with respect to Soliris during that time. According to the complaint, the Company’s revenues attributable to Soliris sales were unsustainable as a result.
If you purchased Alexion stock between February 10, 2014 and November 9, 2016 and suffered a loss on your investment, you are encouraged to contact Marshall P. Dees, Esq. at [email protected], or by toll-free telephone at (888) 508-6832.
The deadline to ask the court to be appointed lead plaintiff is January 17, 2017.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161227005165/en/
